CRT 2025

Panel Discussion | Final Issues and Future Directions

Panel Moderator(s)

• 

  Edward Koifman, MD

  Senior interventional cardiologist
  Wolfson Medical Center, and Tel Aviv University, Israel
  Tel Aviv , Tel Aviv, Israel

  Disclosure(s): Asahi Intecc, Japan: Consultant (Terminated); Boston Scietific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Michael Ragosta, MD

  Director, Cardiac Catheterization Laboratory
  University of Virginia
  Charlottesville, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Robert W. Yeh, MD, MSc

  Professor of Medicine
  Beth Israel Deaconess Medical Center
  Boston, Massachusetts, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); CathWorks: Consultant (Ongoing); Edward Lifesciences: Consultant (Ongoing); Elixir Medical Corporation: Consultant (Ongoing), Grant/Research Support (Ongoing); Magenta Medical: Consultant (Ongoing); Shockwave Medical: Consultant (Ongoing)

Panel Discussant(s)

• 

  Emmanouil S. Brilakis, MD, PhD

  Director, Center for Advanced Coronary Interventions
  Minneapolis Heart Institute
  Minneapolis, Minnesota, United States

  Disclosure(s): Abbott Cardiovascular Systems: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Biotronik: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); boston scientific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cleerly Health: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Elsevier Publishing: royalties (Ongoing); GE Healthcare: Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Haemonetics: Consulting Fees (e.g., advisory boards) (Ongoing); Hippocrates LLC: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); IMDS: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); MHI Ventures: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Stallion Medical: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Teleflex: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); TrueVue Inc: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
• 

  Suhail Dohad, MD

  Medical director of aortic and ischemic limb disease. Director of complex PCI/Endovascular fellowship
  Cedars Sinai Medical Center
  Beverly Hills, California, United States

  Disclosure(s): Abbott Vascular, Boston Scientific, Penumbra, Phillips, ReCOR/Otsuka Pharmaceuticals, Johnson and Johnson: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Dimitri Karmpaliotis, MD, PhD, FACC, FSCAI

  Founder
  Cardiac Intervention Consulting
  New York, New York, United States

  Disclosure(s): No financial relationships to disclose
• 

  Jaikirshan Khatri, MD

  Director of Cardiac Catheterization Laboratory
  Weill Cornell Medical Center, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Tamam Mohamad, MD

  Clinical Professor of Medicine
  Wayne State University School of Medicine
  dearborn, Michigan, United States

  Disclosure(s): No financial relationships to disclose
• 

  Tuomas T. Rissanen, MD, PhD

  Head of Heart Center
  North Karelia Central Hospital
  Joensuu, Pohjois-Karjala, Finland

  Disclosure(s): Abbott Cardiovascular Systems: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); B Braun Medical: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boston Scietific: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Cordis, Endovascular Division: Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Koki Shishido, MD

  Director of Cardiology
  Shonan Kamakura General Hospital
  Kamakura, Japan

  Disclosure(s): Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Adhir Shroff, MD, MPH

  Clinical Chief of Cardiology
  University of Illinois at Chicago/Jesse Brown Medical Center
  Chicago, Illinois, United States

  Disclosure(s): medtronic.: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)